Terms: = Lymphoma AND ELK4, SAP1, 2005, ENSG00000158711, P28324 AND Treatment
804 results:
1. Predictive factors for L-asparaginase hypersensitivity in pediatric acute lymphoblastic leukemia.
Choed-Amphai C; Khorana J; Sathitsamitphong L; Natesirinilkul R; Charoenkwan P
Int J Hematol; 2024 Apr; 119(4):442-449. PubMed ID: 38421487
[TBL] [Abstract] [Full Text] [Related]
2. Primary thyroid lymphoma: a case series.
Sakhri S; Zemni I; Ayadi MA; Kamoun S; Chargui R; Ben Dhiab T
J Med Case Rep; 2024 Feb; 18(1):108. PubMed ID: 38395921
[TBL] [Abstract] [Full Text] [Related]
3. Fine-Needle Aspiration Biopsy as a Diagnostic Modality for Orbital Adnexal lymphoma.
Dan N; Norin C; Dafgård Kopp E; Strömberg O; Tani E; Bohman E
Acta Cytol; 2024; 68(1):26-33. PubMed ID: 38081151
[TBL] [Abstract] [Full Text] [Related]
4. Topography and probability diagram of cervical and intra-parotid lymph node metastasis in parotid gland cancer.
Choi N; Kang YJ; Cho J; Oh D; Jeong J; Jeong HS
Clin Exp Metastasis; 2024 Feb; 41(1):33-43. PubMed ID: 38079016
[TBL] [Abstract] [Full Text] [Related]
5. Frequency of skin cancer among psoriasis, vitiligo, and mycosis fungoides patients treated with narrowband ultraviolet B phototherapy.
Mimouni I; Shulman J; Unes AA; Pavlovsky L; Pavlotsky F
Photodermatol Photoimmunol Photomed; 2024 Jan; 40(1):e12936. PubMed ID: 38059681
[TBL] [Abstract] [Full Text] [Related]
6. Increase in the Life Expectancy of Patients with Cancer in the United States.
Devasia TP; Howlader N; Dewar RA; Stevens JL; Mittu K; Mariotto AB
Cancer Epidemiol Biomarkers Prev; 2024 Feb; 33(2):196-205. PubMed ID: 38015774
[TBL] [Abstract] [Full Text] [Related]
7. A population pharmacokinetic model of methotrexate in Korean patients with haematologic malignancy.
Jung YS; Son M; Lee SG; Chong JW; Kim SJ; Jang JE; Lyu CJ; Hahn SM; Han JW; Park K
Br J Clin Pharmacol; 2024 Mar; 90(3):849-862. PubMed ID: 37984417
[TBL] [Abstract] [Full Text] [Related]
8. Risk of dementia among older patients with lymphoma: A Danish nationwide matched cohort study.
Maksten EF; Jakobsen LH; Modrau B; Jensvoll H; Kragholm KH; Jørgensen JM; Clausen MR; Pedersen RS; Dessau-Arp A; Larsen TS; Poulsen CB; Gang AO; Brown P; El-Galaly TC; Severinsen MT
J Geriatr Oncol; 2024 Jan; 15(1):101672. PubMed ID: 37976653
[TBL] [Abstract] [Full Text] [Related]
9. Opioid and Non-Opioid Pharmacotherapy Use for Pain Management Among Privately Insured Pediatric Patients With Cancer in the United States.
Shen C; Thornton JD; Li N; Schaefer E; Zhou S; Kawasaki S; Pameijer C; Leslie D
Oncologist; 2024 Feb; 29(2):176-184. PubMed ID: 37944042
[TBL] [Abstract] [Full Text] [Related]
10. Impact of multimorbidity and polypharmacy on mortality after cancer: a nationwide registry-based cohort study in Denmark 2005-2017.
Thomsen MK; Løppenthin KB; Bidstrup PE; Andersen EW; Dalton S; Petersen LN; Pappot H; Mortensen CE; Christensen MB; Frølich A; Lassen U; Johansen C
Acta Oncol; 2023 Dec; 62(12):1653-1660. PubMed ID: 37874076
[TBL] [Abstract] [Full Text] [Related]
11. Development and validation of a novel risk stratification model and a survival rate calculator for diffuse large B-cell lymphoma in the rituximab era: a multi-institutional cohort study.
Zhong Q; Chen H; Chen D; Qin Y; He X; Yang Y; Yang J; Liu P; Zhou S; Yang S; Zhou Y; Tang L; Chen C; Shi Y
Ann Hematol; 2024 Jan; 103(1):211-226. PubMed ID: 37861735
[TBL] [Abstract] [Full Text] [Related]
12. Inflammatory Myofibroblastic Tumor With
Schoot RA; Orbach D; Minard Colin V; Alaggio R; Di Carlo D; Corradini N; Mercolini F; Milano GM; van Noesel MM; Rome A; Dall'Igna P; Pajtler K; Sparber-Sauer M; Ferrari A; Casanova M
JCO Precis Oncol; 2023 Sep; 7():e2300323. PubMed ID: 37856763
[TBL] [Abstract] [Full Text] [Related]
13. [Clinical Significance of Minimal Residual Disease in Pediatric Patients with
Xue YJ; Lu AD; Wang Y; Jia YP; Zuo YX; Zhang LP
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2023 Oct; 31(5):1303-1308. PubMed ID: 37846676
[TBL] [Abstract] [Full Text] [Related]
14. Efficacy and Safety of Rituximab-Based treatments in Angioedema With Acquired C1-Inhibitor Deficiency.
Kalmi G; Nguyen Y; Amarger S; Aubineau M; Bibes B; Blanchard-Delaunay C; Boccon-Gibod I; Bouillet L; Coppo P; Dalmas MC; Debord-Peguet S; Defendi F; Demoreuil C; Du-Thanh A; Gayet S; Hadjadj J; Jeandel PY; Launay D; Ly KH; Avoy CM; Niault M; Ollivier Y; Pelletier F; Porneuf M; Roos-Weil D; Fain O; Gobert D
J Allergy Clin Immunol Pract; 2024 Jan; 12(1):212-222. PubMed ID: 37844846
[TBL] [Abstract] [Full Text] [Related]
15. Outcome and characteristics of nonsecretory multiple myeloma compared with secretory multiple myeloma: a retrospective multicenter study from China.
Sun H; Liu A; Liu L; Wang W; Cai Z; Yan H; Chen L; Gao G; Wang F; Liao A; Chen B; Feng J; Li J; Huang DP; Gao D; Zhang QK; Luo J; Fu R; Du J; Lu J
BMC Cancer; 2023 Oct; 23(1):930. PubMed ID: 37784037
[TBL] [Abstract] [Full Text] [Related]
16. Cardiorespiratory fitness and BMI measured in youth and 5-year mortality after site-specific cancer diagnoses in men-A population-based cohort study with register linkage.
Onerup A; Mehlig K; Ekblom-Bak E; Lissner L; Börjesson M; Åberg M
Cancer Med; 2023 Oct; 12(19):20000-20014. PubMed ID: 37732468
[TBL] [Abstract] [Full Text] [Related]
17. Mortality among patients with diffuse large B-cell lymphoma and mental disorders: a population-based study.
Gong IY; Cheung MC; Chan KKW; Arya S; Faught N; Calzavara A; Liu N; Odejide OO; Abel G; Kurdyak P; Raphael MJ; Kuczmarski T; Prica A; Mozessohn L
J Natl Cancer Inst; 2023 Oct; 115(10):1194-1203. PubMed ID: 37531271
[TBL] [Abstract] [Full Text] [Related]
18. Outcomes of patients with indolent lymphoma treated with bendamustine plus rituximab compared to rituximab plus CVP or CHOP chemoimmunotherapy in Ontario.
Suleman A; Aktar SJ; Ante Z; Liu N; Chan KKW; Cheung MC; Prica A
Br J Haematol; 2023 Sep; 202(6):1104-1118. PubMed ID: 37474340
[TBL] [Abstract] [Full Text] [Related]
19. Nelarabine: when and how to use in the treatment of T-cell acute lymphoblastic leukemia.
Shimony S; DeAngelo DJ; Luskin MR
Blood Adv; 2024 Jan; 8(1):23-36. PubMed ID: 37389830
[TBL] [Abstract] [Full Text] [Related]
20. Long-term Outcomes in Primary CNS lymphoma After R-MVP and High-Dose Chemotherapy With Autologous Hematopoietic Stem Cell Transplant.
Therkelsen KE; Schaff LR; Nandakumar S; Omuro AMP; DeAngelis LM; Grommes C
Neurology; 2023 Aug; 101(7):e710-e716. PubMed ID: 37344228
[TBL] [Abstract] [Full Text] [Related]
[Next]
